Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
Disclaimer  << Previous | Next >>
   
Security Code : 519242    Company : SARDA PROTEINS LTD.
01 Aug 2017
Board Meeting On 10Th August, 2017Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  01/08/2017 13:45:36         Exchange Disseminated Time   01/08/2017 13:45:43              Time Taken   00:00:07
Board Meeting on 10th August,2017 to Consider and Approve Un-audited Financial Results for the quarter ended 30th June, 2017.
 
15 Jul 2017
AUDITED FINANCIAL RESULT FOR QUARTER ENDED MARCH,2017 AND FINANCIAL YEAR 2016-17. ResultDownload PDFDownload XBRL
  Exchange Received Time  15/07/2017 17:48:15         Exchange Disseminated Time   15/07/2017 17:48:25              Time Taken   00:00:10
Results and Statement of Assets and Liabilities as on 31st March, 2017 as per Schedule III , Companies Act, 2013.
 
10 Jul 2017
Shareholding for the Period Ended June 30, 2017Company Update 
  Exchange Disseminated Time     10/07/2017 09:03:07
Sarda Proteins Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
 
Statement Of Investor Complaints For The Quarter Ended On 30Th June, 2017 Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  10/07/2017 00:07:50         Exchange Disseminated Time   10/07/2017 00:07:57              Time Taken   00:00:07
Cover Letter And Statement For Investor Complaints
 
27 May 2017
AUDITED FINANCIAL RESULT FOR QUARTER ENDED MARCH,2017 AND FINANCIAL YEAR 2016-17.ResultDownload PDFDownload XBRL
  Exchange Received Time  27/05/2017 18:15:55         Exchange Disseminated Time   27/05/2017 18:16:01              Time Taken   00:00:06
AUDITED FINANCIAL RESULT FOR QUARTER ENDED MARCH,2017 AND FINANCIAL YEAR 2016-17.
 
Outcome of Board MeetingBoard MeetingDownload PDFDownload XBRL
  Exchange Received Time  27/05/2017 18:02:48         Exchange Disseminated Time   27/05/2017 18:02:55              Time Taken   00:00:07
OUTCOME OF THE FIRST BOARD MEETING FOR FINANCIAL YEAR 2017-18 HELD ON MAY,27,2017.
 
19 May 2017
Closure of Trading WindowInsider Trading / SASTDownload PDFDownload XBRL
  Exchange Received Time  19/05/2017 10:44:10         Exchange Disseminated Time   19/05/2017 10:44:16              Time Taken   00:00:06
Pursuant to SEBI(Prohibition of Insider Trading) Regulations 2015, Closure of Trading Window from May 18,2017 till the end of 48 hours from conclusion of meeting.
 
Intimation Of The 1St Board Meeting For The Financial Year 2017-18 To Approve Audited Financial Results For Quarter And Year Ended 31-03-2017.Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  19/05/2017 10:33:59         Exchange Disseminated Time   19/05/2017 10:34:10              Time Taken   00:00:11
Intimation for Board Meeting to approve the Audited Financial Results for Quarter And Year Ended 31-03-2017
 
14 Apr 2017
PCS CERTIFICATE HALF YEARLYCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  14/04/2017 11:45:50         Exchange Disseminated Time   14/04/2017 11:45:55              Time Taken   00:00:05
Cover Letter And Certificate
 
Compliance Certificate ( RTA & COMPLIANCE OFFICER)Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  14/04/2017 11:40:44         Exchange Disseminated Time   14/04/2017 11:40:49              Time Taken   00:00:05
Cover Letter And Compliance Certificate
 
Statement For Investor Complaints For The Quarter Ended March, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  14/04/2017 11:31:38         Exchange Disseminated Time   14/04/2017 11:31:44              Time Taken   00:00:06
Cover Letter And Statement For Investor Complaints
 
07 Apr 2017
Shareholding for the Period Ended March 31, 2017Company Update 
  Exchange Disseminated Time     07/04/2017 09:55:16
Sarda Proteins Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
 
04 Apr 2017
Statement Of Investor Complaints For The Quarter Ended On 31St March, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  04/04/2017 12:37:55         Exchange Disseminated Time   04/04/2017 12:37:59              Time Taken   00:00:04
With regard to the captioned subject, please find enclosed herewith the Statement of Investors Complaints pursuant to Regulations 13(3) of SEBI (Listing Obligations and Disclosures Requirements), Regulations, 2015 for the quarter ended as on 31st March, 2017.
 
28 Jan 2017
  Outcome of Board MeetingBoard MeetingDownload PDF
  Exchange Disseminated Time     28/01/2017 17:28:41
Sarda Proteins Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 28, 2017, which commenced at 04:00 P.M. and concluded at 05.00 P.M., inter alia, has transacted the following business:

1. Took on record the re-appointment of Mr. Damodar Prasad Sarda as a Whole-Time-Director as a Key Managerial Personnel of the Company under section 196, 197,198 and 203 of Companies Act, 2013 for a further period of three years. ....
Standalone Financial Results, Limited Review Report for December 31, 2016ResultDownload PDF
  Exchange Disseminated Time     28/01/2017 17:27:36
Sarda Proteins Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Standalone Limited Review for the period ended December 31, 2016
 
19 Jan 2017
  Board Meeting Intimation for Results & Closure of Trading WindowBoard MeetingDownload PDF
  Exchange Disseminated Time     19/01/2017 13:42:26
Sarda Proteins Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on January 28, 2017, inter alia, to consider and approve the Unaudited Financial Results of the Company and to take on record Limited Review Report thereon for the quarter/nine months ended on December 31, 2016.

Further, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read ....
10 Jan 2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016Company UpdateDownload PDF
  Exchange Disseminated Time     10/01/2017 12:19:00
Sarda Proteins Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 
09 Jan 2017
Shareholding for the Period Ended December 31, 2016Company Update 
  Exchange Disseminated Time     09/01/2017 12:39:20
Sarda Proteins Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here
 
05 Nov 2016
Standalone Financial Results, Limited Review Report for September 30, 2016ResultDownload PDF
  Exchange Disseminated Time     05/11/2016 19:30:37
Sarda Proteins Ltd has informed BSE about :

1. Standalone Financial Results for the period ended September 30, 2016

2. Standalone Limited Review for the period ended September 30, 2016
 
UpdatesCompany UpdateDownload PDF
  Exchange Disseminated Time     05/11/2016 19:29:37
Sarda Proteins Ltd has informed BSE that Mr. Badri Bishal Sarda, an Independent Director of the Company ceased to be director of the Company w.e.f. November 05, 2016 consequent to his vacation of office of Director under the provisions of section 167 (1) (b) of Companies Act, 2013.
 

Disclaimer << Previous | Next >>